Clinical Trials Sponsored by Asieris Pharmaceutical Technologies Co., Ltd.

Total 3906 results

Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

Bipolar Disorders | Metabolic Complication

Korea, Republic of
Chonnam National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Unknown

Busulfan and Melphalan Conditioning in Multiple Myeloma

Multiple Myeloma

Korea, Republic of
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

Depression

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University

Unknown

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Solid Tumor

China
Japan Clinical Cancer Research Organization
Taiho Pharmaceutical Co., Ltd.

Unknown

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

Rectal Carcinoma

Japan
Seoul National University Hospital
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a

Healthy

Korea, Republic of
Japan Clinical Cancer Research Organization
Taiho Pharmaceutical Co., Ltd.

Completed

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Gastric Cancer

Japan
Nang Kuang Pharmaceutical Co., Ltd.
National Taiwan University Hospital

Terminated

Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

Cardiovascular Disease | Type 2 Diabetes Mellitus | Hypercholesterolemia

Taiwan
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects

Healthy

China
Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

Schizophrenia

Korea, Republic of
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Seoul National University Bundang Hospital
Daewoong Pharmaceutical Co. LTD.

Recruiting

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Type 2 Diabetes

Korea, Republic of
Sun Yat-sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma

China
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

SLE

China
Sun Yat-sen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Metastatic Biliary Tract Cancer | Locally Advanced Biliary Tract Cancer

China
Zhongshan Hospital Xiamen University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study

Stage IV Gastric Cancer With Metastasis
Seoul National University Bundang Hospital
Daewon Pharmaceutical Co., Ltd.

Recruiting

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Diabetes Mellitus, Type 2 | Atherosclerosis | Dyslipidemia

Korea, Republic of
Wuhan Union Hospital, China
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients

Primary Immune Thrombocytopenia
Ruijin Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) (ALTER-G-001)

Gastrointestinal Tumors

China
Conjupro Biotherapeutics, Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors

Solid Tumor

United States
Ascentage Pharma Group Inc.
Suzhou Yasheng Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.

Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)

China
Keimyung University Dongsan Medical Center
Otsuka Pharmaceutical Co., Ltd.

Recruiting

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas (RRTCLAlloSCT)

Lymphoma, Extranodal NK-T-Cell | T-cell Non-Hodgkin Lymphoma

Korea, Republic of
RDO Pharm.
Beijing Pharbers Genesis Pharmaceutical Technology Co., Ltd.

Completed

99mTc-3PRGD2 SPECT/CT for Integrin Imaging of Lung Cancer (TRIIL)

Lung Cancer | Lymph Node Metastasis

China
National Cancer Center Hospital East
Ono Pharmaceutical Co. Ltd

Active, not recruiting

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

Anaplastic Thyroid Cancer

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd; Seagen Inc.

Terminated

A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, (CheckMate 812)

Hodgkin's Disease

United States, Japan, Puerto Rico
Nang Kuang Pharmaceutical Co., Ltd.
Taichung Veterans General Hospital

Completed

Clinical Study for Assessment of the Efficacy of Gabapentin (Carbatin and Neurontin) in Patients With Neuropathy Pain

Pain | Neuropathy

Taiwan
Peking University People's Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Enrolling by invitation

Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer

Germline BRCA-mutated HER2-negative Breast Cancer

China
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd; Nektar Therapeutics

Completed

An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors

Advanced Cancer

Japan
Shenyang Sunshine Pharmaceutical Co., LTD.
Navitas Life Sciences GmbH

Terminated

Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study) (BEAT_001)

Renal Anaemia

Thailand
Peking Union Medical College
CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

Breast Cancer

China
Tongji Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) (Neptune)

Chronic Hepatitis b
Beijing Tide Pharmaceutical Co., Ltd
Peking University First Hospital

Unknown

Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury

Myocardial Reperfusion Injury

China
Beijing Tongren Hospital
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Completed

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

Seasonal Allergic Rhinitis

China
The University of Hong Kong
Taiho Pharmaceutical Co., Ltd.

Completed

Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis

Gastric Cancer | Peritoneal Carcinomatosis

China
Beijing Tongren Hospital
Chengdu Rhodiola Bio-Pharmaceutical Co Ltd

Unknown

Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects

Blepharokeratoconjunctivitis

China
Boryung Pharmaceutical Co., Ltd
The Catholic University of Korea

Completed

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

Peptic Ulcer

Korea, Republic of
Peking University First Hospital
Zhejiang Otsuka Pharmaceutical Co., Ltd.

Completed

Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions (CAVAD)

Stroke | Vascular Dementia

China
UCB BIOSCIENCES GmbH
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease

Advanced Parkinson's Disease

Australia, Korea, Republic of, Malaysia, Singapore, Taiwan
Peking Union Medical College
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP

Thrombocytopenia | Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura

China
Seoul National University Hospital
Dong-A Pharmaceutical Co., Ltd.

Completed

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Raynaud Phenomenon

Korea, Republic of
Chonbuk National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Aripiprazole in First Episode Psychosis

First Episode Psychosis

Korea, Republic of
Hospital Authority, Hong Kong
Kirin Pharmaceutical (Asia) CO., LTD

Completed

Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

Anemia | Kidney Failure, Chronic | Peritoneal Dialysis, Continuous Ambulatory

China
Kyowa Kirin Pharmaceutical Development Ltd
Apices Soluciones S.L.

Completed

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC. (NACASY)

Opioid Induced Constipation

Netherlands, Sweden, Finland, Denmark, Spain, France, Germany, Greece, Italy, United Kingdom
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Recruiting

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

SARS-CoV-2

China
The First Affiliated Hospital of Zhengzhou University
BeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.

Not yet recruiting

Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy

HER2-positive or Mutated Advanced Colorectal Cancer
The First Affiliated Hospital of Soochow University
Biotech Pharmaceutical Co., Ltd.; Cinda Biopharmaceutical (Suzhou) Co., Ltd.

Not yet recruiting

Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (Carpp-1)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Not yet recruiting

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

SARS-CoV-2
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
LENZ Therapeutics, Inc

Recruiting

Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia

Eye Diseases | Presbyopia | Miosis | Near Vision

China

Clinical Trials Sponsored by Asieris Pharmaceutical Technologies Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations